Back to top

Introducing World’s First Integrated automated & close-loop manufacturing of Viral Vector & Vaccines

CellBRx® Integrated Seed Train (CellBRx® -IST)

A groundbreaking innovation in biopharmaceutical manufacturing – CellBRx®-IST is world’s first Fully Integrated, Automated, and Closed-loop system for manufacturing Viral Vectors and Vaccines.

CellBRx<sup>®</sup>-IST
+
+
+
+
+
+
+
+
+
+
+
+
+
+

Applications

From perfusion optimization to personalized medicine, explore our diverse applications for pioneering bioprocessing features:
  • Vaccines

    Vaccines

    Scalable bioreactors ideal for inactivated and viral vector-based vaccine production - supporting both research & commercial cGMP operations.

  • Viral Vectors

    Viral Vectors

    Designed for high-yield production of Lentiviral & AAV vectors, bioreactor systems ensure controlled productivity from bench to clinical scale.

  • Stem Cells

    Stem Cells

    Single-use bioreactors designed for consistent expansion and cell recovery of stem cells in adherent & suspension formats.

  • Exosomes

    Exosomes

    Precision-engineered systems tailored for scalable exosome production and harvest, enabling consistent particle yield at large scale.

  • Therapeutic proteins & Hormones

    Therapeutic proteins & Hormones

    Versatile bioreactor systems for recombinant protein expression in mammalian hosts, ensuring consistent process control and production yield.

  • Cultured Meat

    Cultured Meat

    Bioreactors built for scalable production of animal cell-based meat, supporting myoblast, adipocyte, & scaffold-associated tissue growth under cGMP.

Integrated Seed Train (IST) Process Flow

Integrated Excellence:

Smarter, Scalable, and affordable Biomanufacturing

  • Seamless Process Efficiency
  • Cost-effectiveness
  • Accessibility
  • Quality and Compliances
Seamless Process Efficiency
  • 01

    The CellBRx®-IST platform revolutionizes seed train development with a fully integrated, automated, and closed-loop system that ensures unmatched process efficiency from bench to GMP-scale manufacturing. By eliminating manual handling, reducing contamination risks, and minimizing media consumption by up to 50%, it streamlines inoculum generation with high reproducibility and rapid turnaround. Its stepwise scaling approach using SeedBRx units mirrors production-scale environments, enabling direct process transfer without re-optimization. Integrated monitoring, perfusion control, and high surface-area-to-volume efficiency ensure consistent cell quality and optimal resource utilization—empowering faster, leaner, and more reliable biomanufacturing.

Cost-effectiveness
  • 01

    The CellBRx®-IST platform delivers substantial cost savings by replacing traditional, labor-intensive seed trains with a compact, automated bioreactor system. Its closed design reduces contamination risks and eliminates the need for CO₂ incubators and multiple 2D culture vessels—freeing up valuable facility space and reducing capital expenditure. Integrated perfusion and high surface-area 3D matrices enable efficient nutrient utilization, cutting growth media usage by up to 50%. Lower labor input, faster batch readiness, and reduced consumable requirements translate into significantly lower operational costs, making CellBRx-IST a highly economical solution for adherent cell culture scale-up.

Accessibility
  • 01

    The CellBRx®-IST platform plays a pivotal role in democratizing access to life-saving therapies by enabling rapid, scalable, and cost-efficient manufacturing of vaccines, gene therapies, and cell-based treatments. Its closed, automated seed train design reduces infrastructure dependency and lowers production costs, making biomanufacturing more feasible even in resource-constrained settings. By accelerating time-to-batch and ensuring consistent cell quality, CellBRx-IST supports faster development cycles and higher throughput. This empowers manufacturers to bring critical biologics to market more quickly and at accessible price points—expanding global reach and patient impact.

Quality and Compliances
  • 01

    The CellBRx®-IST platform is meticulously engineered to meet the stringent demands of cGMP-compliant biomanufacturing. All product-contact components are biocompatible, animal-origin-free, and manufactured in ISO 14644-Class 8 cleanroom environments, with sterility validated as per ISO 11137. The integrated SCADA-based control system ensures precise process monitoring, electronic data integrity, and 21 CFR Part 11 and GAMP 5 compliance. With comprehensive support for DQ, IQ, OQ, and PQ documentation, CellBRx-IST offers a regulatory-ready solution that ensures consistent product quality, traceability, and audit preparedness across clinical and commercial production.

WHY CellBRx-IST?

Compared to conventional seed train using 2D multilayer cell stacks, CellBRx-IST can reduce:

Consumable Cost
54%
Facility Footprint
85%
Manpower Requirement
73%
Capital Expenditure (CapEx)
47%
Process Failure List
78%
Growth Media Requirement
52%

Frequently Asked Questions

How and Why Has OmniBRx Conceptualized and Brought the CellBRx IST Platform?

OmniBRx conceptualized the CellBRx Integrated Seed Train (IST) platform to address a critical bottleneck in the scale-up of adherent cell culture—the inefficiency and inconsistency of manual flask-based seed train processes. Traditional methods are labor-intensive, prone to contamination, and difficult to standardize across scales. Recognizing the growing demand for scalable, GMP-compliant adherent cell manufacturing—especially in vaccines, viral vectors, and cell therapy—OmniBRx engineered the IST platform to automate and streamline the inoculum development phase. The CellBRx IST platform integrates SeedBRx bioreactors of varying surface areas in a stepwise, closed-loop system that mirrors the production-scale environment. This enables a seamless transition from research to commercial manufacturing without compromising cell health, attachment efficiency, or process control. By minimizing manual intervention and offering consistent scalability, the IST platform empowers bioprocess teams to reduce seed train timelines, improve reproducibility, and accelerate time-to-batch—making it a transformative solution for modern adherent cell culture workflows.

What Are the Major Benefits of the CellBRx IST Platform?

The CellBRx Integrated Seed Train (IST) platform delivers a transformative advantage for adherent cell culture processes by enabling a closed, scalable, and highly efficient seed train solution. Its major benefits include: 1) Closed System Operation, 2) Time and Labor Efficiency, 3) Enhanced Cell Quality and Viability, 4) Faster Turnaround, 5) Process Standardization, 6) Integrated Monitoring and Control

How CellBRx-IST can reduce growth media consumption during seed development stages compared to conventional seed train?

The CellBRx-IST platform significantly reduces growth media consumption during seed train development by replacing multiple conventional 2D culture vessels (like T-flasks, roller bottles, or cell stacks) with a compact bioreactor system that offers a high surface-area-to-volume ratio. In traditional seed trains, large volumes of media are required to support adherent cell growth across numerous 2D culture devices, each with low efficiency in nutrient utilization and use of larger facility footprint using CO2 incubators. In contrast, CellBRx-IST enables densely packed cell growth on a 3D matrix within a closed environment, allowing more efficient nutrient delivery and waste removal with substantially less media per unit of cell growth. Additionally, its integrated perfusion mode allow precise control over media usage, supplying nutrients only as needed and minimizing wastage. As a result, bioprocess teams can achieve the desired inoculum with up to 40–60% less media, reducing both operational cost and environmental footprint.

How Can I Contact a Technical Expert at OmniBRx, and Can I Request a Live Demo of the CellBRx-IST System?

You can reach out to our technical team at OmniBRx by filling out the contact form on our website or by emailing us directly at info@omnibrx.com or Sales@omnibrx.com. Our team of application specialists and process engineers will promptly get in touch to understand your specific requirements and provide expert guidance on the CellBRx-IST bioreactor system. Yes, we do offer live demonstrations of the CellBRx-IST platform - either virtually or on-site at our Application Lab or customer facility (subject to availability). These demos provide a hands-on overview of system features, setup, operation, and performance metrics, tailored to your bioprocess needs. To schedule a demo, click “Need A Live Demo? Tab or simply mention your interest in your inquiry, and our team will coordinate the next steps.

Can CellBRx-IST be customized for our specific cell type and production process?

Yes. The CellBRx-IST platform is highly adaptable and can be tailored to suit your specific adherent cell line and process parameters. OmniBRx’s technical team works closely with your scientists to design a custom seed train configuration, optimize culture conditions, and ensure smooth integration into your upstream workflow—whether for vaccines, viral vectors, stem cells, or gene therapy applications.